Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Other Non-Current Liabilities (2019 - 2026)

Veracyte's Other Non-Current Liabilities history spans 9 years, with the latest figure at $257000.0 for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities fell 37.47% to $257000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $257000.0, a 37.47% decrease, with the full-year FY2025 number at $257000.0, down 37.47% from a year prior.
  • Other Non-Current Liabilities hit $257000.0 in Q4 2025 for Veracyte, down from $583000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for VCYT hit a ceiling of $14.2 million in Q3 2024 and a floor of $257000.0 in Q4 2025.
  • Historically, Other Non-Current Liabilities has averaged $3.0 million across 5 years, with a median of $1.6 million in 2021.
  • Biggest five-year swings in Other Non-Current Liabilities: surged 1733.12% in 2024 and later plummeted 95.9% in 2025.
  • Tracing VCYT's Other Non-Current Liabilities over 5 years: stood at $1.4 million in 2021, then soared by 77.54% to $2.5 million in 2022, then tumbled by 68.53% to $786000.0 in 2023, then plummeted by 47.71% to $411000.0 in 2024, then plummeted by 37.47% to $257000.0 in 2025.
  • Business Quant data shows Other Non-Current Liabilities for VCYT at $257000.0 in Q4 2025, $583000.0 in Q3 2025, and $573000.0 in Q2 2025.